共 19 条
[4]
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2003, 21 (22)
:4112-4119
[6]
Jiasheng L., 2018, Clin J Chin Med, V10, P34
[7]
Lu D R., 2018, Zhenjiu Linchuang Zazhi, V34, P81
[10]
A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy
[J].
JAPANESE JOURNAL OF CLINICAL ONCOLOGY,
2019, 49 (02)
:121-129